Skip to main content
. 2023 Mar 6;47(4):539–547. doi: 10.1097/RCT.0000000000001448

TABLE 2.

Comparisons of Imaging Features in Training and Validation Cohort

Imaging Features Training Cohort (n = 77) Validation Cohort (n = 33)
Low Ki67 Group (n = 27) High Ki67 Group (n = 50) P Low Ki67 Group (n = 11) High Ki67 Group (n = 22) P
Maximum length, median (IQR), cm 3.5 (2.3–5.0) 4.3 (2.3–7.2) 0.337 2.5 (1.2–3.8) 4.9 (3.6–8.4) 0.009
No. tumors (%) 0.377 0.681
 Solitary 16 (59.3) 36 (72.0) 9 (81.8) 15 (68.2)
 Multiple 11 (40.7) 14 (28.0) 2 (18.2) 7 (31.8)
Tumor margin (%) 0.049 0.036
 Smooth 20 (74.1) 24 (48.0) 9 (81.8) 8 (36.4)
 Nonsmooth 7 (25.9) 26 (52.0) 2 (18.2) 14 (63.6)
Peritumoral arterial enhancement (%) 0.125 0.259
 Absent 23 (85.2) 33 (66.0) 9 (81.8) 13 (59.1)
 Present 4 (14.8) 17 (34.0) 2 (18.2) 9 (40.9)
Enhancement pattern (%) 1 1
 Typical 26 (96.3) 47 (94.0) 10 (90.9) 21 (95.5)
 Atypical 1 (3.7) 3 (6.0) 1 (9.1) 1 (4.5)
Tumor hypointensity on HBP (%) 1 1
 Present 25 (92.6) 47 (94.0) 10 (90.9) 19 (86.4)
 Absent 2 (7.4) 3 (6.0) 1 (9.1) 3 (13.6)
Peritumoral hypointensity on HBP (%) 0.119 0.687
 Absent 25 (92.6) 38 (76.0) 10 (90.9) 19 (86.4)
 Present 2 (7.4) 12 (24.0) 1 (9.1) 3 (13.6)
Radiologic capsule (%) 0.948 0.121
 Present 22 (81.5) 39 (78.0) 6 (54.5) 18 (81.8)
 Absent 5 (18.5) 11 (22.0) 5 (45.5) 4 (18.2)
SITumor (b = 800 s/mm2) 124.8 (13.8) 188.7 (16.2) 0.014 122.8 (47.8) 168.4 (95.6) 0.148
SIBackground (b = 800 s/mm2) 6.1 (0.6) 6.4 (0.4) 0.439 7.0 (0.8) 6.1 (0.7) 0.259
SILiver (b = 800 s/mm2) 55.0 (6.6) 67.7 (6.2) 0.219 54.4 (21.0) 54.7 (32.5) 0.975
ADCTumor (×10−3 mm2/s) 1075.7 (55.1) 1003.4 (35.1) 0.127 1146.4 (78.4) 1045.1 (51.3) 0.237
SNR 44.9 (6.0) 67.9 (5.8) 0.014 44.2 (17.2) 60.6 (34.4) 0.148
Contrast 2.5 (0.2) 3.1 (0.2) 0.121 2.6 (0.4) 3.5 (0.4) 0.079

P-values are statistically significant in boldface format.